BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2612502)

  • 21. [Superior sagittal sinus thrombosis following L-asparaginase therapy of acute lymphoblastic leukemia].
    Watanabe I; Sakai I; Matsumoto I
    Rinsho Ketsueki; 1992 Mar; 33(3):343-8. PubMed ID: 1578639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study.
    Mitchell L; Andrew M; Hanna K; Abshire T; Halton J; Wu J; Anderson R; Cherrick I; Desai S; Mahoney D; McCusker P; Chait P; Abdolell M; de Veber G; Mikulis D
    Thromb Haemost; 2003 Aug; 90(2):235-44. PubMed ID: 12888870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia.
    Lim HL; Teo CP; Wong K; Kueh YK
    Singapore Med J; 1998 Feb; 39(2):76-8. PubMed ID: 9652181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hypercoagulation by antithrombin substitution in E. coli L-asparaginase-treated children.
    Nowak-Göttl U; Kuhn N; Wolff JE; Boos J; Kehrel B; Rath B; Jürgens H
    Eur J Haematol; 1996; 56(1-2):35-8. PubMed ID: 8599991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cryoprecipitate-induced mesenteric venous thrombosis during L-asparaginase therapy for acute lymphoblastic leukaemia.
    Musa MO; Al-Fair F; Al-Mohareb F; Al-Saeed H; Aljurf M
    Leuk Lymphoma; 2001 Jan; 40(3-4):429-31. PubMed ID: 11426567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravascular coagulation phenomena associated with prevalent fall in fibrinogen and plasminogen during L-asparaginase treatment in leukemic children.
    Legnani C; Palareti G; Pession A; Poggi M; Vecchi V; Bianchini B; Coccheri S
    Haemostasis; 1988; 18(3):179-86. PubMed ID: 3181817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
    Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
    Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cerebral sinovenous thrombosis and acquired antithrombin, protein C and S deficiency during chemotherapy in a young man: report of a case].
    Munoz VT; Triffet A; Cauchie P; Brohée D
    Rev Med Brux; 2008; 29(6):535-9. PubMed ID: 19202708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
    Bhojwani D; Darbandi R; Pei D; Ramsey LB; Chemaitilly W; Sandlund JT; Cheng C; Pui CH; Relling MV; Jeha S; Metzger ML
    Eur J Cancer; 2014 Oct; 50(15):2685-94. PubMed ID: 25087182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current national and international status of supportive therapy for the coagulopathy associated with L-asparaginase containing regimen for acute lymphoblastic leukemia].
    Ogawa C; Manabe A; Ohara A; Ishiguro A
    Rinsho Ketsueki; 2013 Mar; 54(3):316-8. PubMed ID: 23676650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Greater decrease of fibrinogen as compared to antithrombin III in L-asparaginase treated leukemia patients.
    Vicarioto M; Rosolen A; Cappellato MG; Zanesco L; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):663-9. PubMed ID: 2435632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different profile of thrombin generation in children with acute lymphoblastic leukaemia treated with native or pegylated asparaginase: A cohort study.
    Rozen L; Noubouossie D; Dedeken L; Huybrechts S; Lê PQ; Ferster A; Demulder A
    Pediatr Blood Cancer; 2017 Feb; 64(2):294-301. PubMed ID: 27605400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro study.
    Kuhle S; Lau A; Bajzar L; Vegh P; Halton J; Cherrick I; Anderson R; Desai S; McCusker P; Wu J; Abshire T; Mahoney D; Mitchell L
    Br J Haematol; 2006 Sep; 134(5):526-31. PubMed ID: 16856890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of prophylactic fresh-frozen plasma and cryoprecipitate on the incidence of central nervous system thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase.
    Abbott LS; Deevska M; Fernandez CV; Dix D; Price VE; Wang H; Parker L; Yhap M; Fitzgerald C; Barnard DR; Berman JN
    Blood; 2009 Dec; 114(25):5146-51. PubMed ID: 19822902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-asparaginase-induced reversible posterior leukoencephalopathy syndrome in a child with acute lymphoblastic leukemia.
    Rathi B; Azad RK; Vasudha N; Hissaria P; Sawlani V; Gupta RK
    Pediatr Neurosurg; 2002 Oct; 37(4):203-5. PubMed ID: 12372914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinopeptide A changes during remission induction treatment with L-asparaginase in acute lymphoblastic leukemia: evidence for activation of blood coagulation.
    Rodeghiero F; Castaman G; Dini E
    Thromb Res; 1990 Jan; 57(1):31-8. PubMed ID: 2300923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of L-asparaginase in acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group.
    Piatkowska-Jakubas B; Krawczyk-Kuliś M; Giebel S; Adamczyk-Cioch M; Czyz A; Lech Marańda E; Paluszewska M; Pałynyczko G; Piszcz J; Hołowiecki J;
    Pol Arch Med Wewn; 2008 Nov; 118(11):664-9. PubMed ID: 19140571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-asparaginase induced antithrombin III deficiency: evidence against the production of a hypercoagulable state.
    Bauer KA; Teitel JM; Rosenberg RD
    Thromb Res; 1983 Feb; 29(4):437-42. PubMed ID: 6857592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression of functional and antigenic plasma antithrombin III (AT-III) due to therapy with L-asparaginase.
    Liebman HA; Wada JK; Patch MJ; McGehee W
    Cancer; 1982 Aug; 50(3):451-6. PubMed ID: 7046902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular complications of sigmoid sinus thrombosis from L-asparaginase.
    Foroozan R
    J Pediatr Ophthalmol Strabismus; 2005; 42(2):117-9. PubMed ID: 15825749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.